Literature DB >> 12821755

Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients.

F Baskin1, R N Rosenberg, X Fang, L S Hynan, C B Moore, M Weiner, G L Vega.   

Abstract

Platelets, like neurons, contain 120- to 130- and 110-kd amyloid precursor proteins (APPs). Their ratio is reduced in AD, further reductions correlating with reduced Mini-Mental Status Examination scores [r(11) = 0.69, p < 0.05]. As statins alter APP processing, platelet APPs were analyzed in patients with AD given anticholesterol drugs for 6 weeks. APP ratios increased [t(37) = -3.888, p = 0.0004], proportionally with reduced cholesterol [r(36) = -0.45, p = 0.005]. Longer trials may reveal slowed cognitive loss, validating this index.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821755     DOI: 10.1212/01.wnl.0000068029.56740.96

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Authors:  Geneviève Evin; Qiao-Xin Li
Journal:  World J Psychiatry       Date:  2012-12-22

Review 2.  Biomarkers of Alzheimer disease in plasma.

Authors:  Michael C Irizarry
Journal:  NeuroRx       Date:  2004-04

Review 3.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

4.  Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.

Authors:  Kun Tang; Linda S Hynan; Fred Baskin; Roger N Rosenberg
Journal:  J Neurol Sci       Date:  2005-10-26       Impact factor: 3.181

Review 5.  Translational research on the way to effective therapy for Alzheimer disease.

Authors:  Roger N Rosenberg
Journal:  Arch Gen Psychiatry       Date:  2005-11

Review 6.  Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism.

Authors:  Walter J Lukiw; Miguel Pappolla; Ricardo Palacios Pelaez; Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.